Legal & General Group
OPRX icon

Legal & General Group’s OptimizeRx OPRX Stock Holding History

Legal & General Group’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,350
Closed -$8.48K – 3499
2026
Q1 		$8.48K Sell
1,350
-230
-15% -$2.14K ﹤0.01% 3223
2025
Q4 		$19.4K Sell
1,580
-78
-5% -$1.27K ﹤0.01% 3042
2025
Q3 		$34K Sell
1,658
-304
-15% -$4.82K ﹤0.01% 2831
2025
Q2 		$26.5K Sell
1,962
-219
-10% -$2.4K ﹤0.01% 2895
2025
Q1 		$18.9K Hold
2,181
– – ﹤0.01% 2963
2024
Q4 		$10.6K Hold
2,181
– – ﹤0.01% 3243
2024
Q3 		$16.8K Buy
2,181
+428
+24% +$3.8K ﹤0.01% 3117
2024
Q2 		$17.5K Buy
1,753
+42
+2% +$461 ﹤0.01% 3080
2024
Q1 		$20.8K Hold
1,711
– – ﹤0.01% 2944
2023
Q4 		$24.5K Sell
1,711
-203
-11% -$1.95K ﹤0.01% 2951
2023
Q3 		$14.9K Hold
1,914
– – ﹤0.01% 3146
2023
Q2 		$27.4K Hold
1,914
– – ﹤0.01% 2980
2023
Q1 		$28K Sell
1,914
-40,192
-95% -$673K ﹤0.01% 2977
2022
Q4 		$707K Sell
42,106
-340
-0.8% -$5.88K ﹤0.01% 2243
2022
Q3 		$629K Sell
42,446
-7,269
-15% -$144K ﹤0.01% 2284
2022
Q2 		$1.36M Buy
49,715
+5,823
+13% +$173K ﹤0.01% 2044
2022
Q1 		$1.66M Sell
43,892
-257
-0.6% -$11.4K ﹤0.01% 2060
2021
Q4 		$2.74M Buy
44,149
+36,162
+453% +$2.74M ﹤0.01% 1877
2021
Q3 		$683K Buy
7,987
+5,054
+172% +$317K ﹤0.01% 2336
2021
Q2 		$180K Buy
2,933
+1,145
+64% +$58.3K ﹤0.01% 2563
2021
Q1 		$87K Buy
1,788
+16
+0.9% +$772 ﹤0.01% 2655
2020
Q4 		$55K Sell
1,772
-34
-2% -$833 ﹤0.01% 2774
2020
Q3 		$38K Sell
1,806
-555
-24% -$9.53K ﹤0.01% 2780
2020
Q2 		$31K Sell
2,361
-2
-0.1% -$22 ﹤0.01% 2882
2020
Q1 		$21K Sell
2,363
-685
-22% -$6.5K ﹤0.01% 2893
2019
Q4 		$31K Buy
3,048
+538
+21% +$6.1K ﹤0.01% 3028
2019
Q3 		$36K Buy
2,510
+513
+26% +$7.94K ﹤0.01% 2881
2019
Q2 		$32K Buy
+1,997
New +$27K ﹤0.01% 2983

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Legal & General Group's OPRX Position: Q2 2026 in Review

Legal & General Group sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 1,350 shares — an estimated $8.48K sold.

Legal & General Group first reported a position in OPRX in Q2 2019 and held it in 28 quarters. The position peaked at $2.74M in Q4 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Legal & General Group reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 1,350 OptimizeRx shares in Q2 2026, an estimated $8.48K.
  • Legal & General Group first reported a position in OptimizeRx in Q2 2019 and held it in 28 quarters.
  • Legal & General Group's OptimizeRx position peaked at $2.74M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.